Ivermectin fails in double blind study, plus another paper withdrawn

The Rocketry Forum

Help Support The Rocketry Forum:

manixFan

Not a rocket scientist
Joined
Feb 15, 2009
Messages
2,004
Reaction score
980
Location
TX

"Cumulatively, the findings suggest that ivermectin does not significantly affect the course of early COVID-19, consistent with pharmacokinetic models showing that plasma total and unbound ivermectin levels do not reach the concentration resulting in 50% of viral inhibition even for a dose level 10-times higher than the approved dose," the authors concluded.

"The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes."

Further, a paper that had been accepted that appeared to be positive was withdrawn, citing numerous issues with the paper, including "“a series of strong, unsupported claims based on studies with insufficient statistical significance, and at times, without the use of control groups.”



Tony
 
Last edited:

cwbullet

Obsessed with Rocketry
Staff member
Administrator
TRF Lifetime Supporter
Global Mod
Joined
Jan 24, 2009
Messages
26,779
Reaction score
4,334
Location
Glennville, GA
Suspected as much. The intial study was a perfect example of bias.
 
Top